Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 164: Emily Chee, US General Manager of Novartis Gene Therapies
Yours, Mine and Ours (not yet!): An Update on the Patentability of Human Genes -
On January 11, 2026, the FDA issued two news releases putting forward reforms to the chemistry, manufacturing, and control requirements for cell and gene therapy products, one titled FDA Increases Flexibility on Requirements...more
On November 13, 2025, the Genetic Technology (Precision Breeding) Regulations 2025 (“2025 PB regulations”) took effect, completing the United Kingdom’s (UK’s) post-Brexit framework for gene-edited plants. The Regulations...more
In 2025, Life Sciences and Health Care (LS&HC) companies face rapidly evolving regulatory paradigms that create transactional risks and require daily monitoring. After more than 70 national elections in 2024, the dust hasn’t...more
Welcome to the Summer of Privacy! As we hit the middle of 2025, California is once again the focus of our attention, as both its legislators and regulators are attempting to square privacy protections with developing...more
Governor Mark Gordon signed the Wyoming Genetic Data Privacy Act into law on March 8, 2022. The law goes into effect on July 1, 2022. The Genetic Data Privacy Act requires any business that collects genetic data from...more